Holen Sie sich die Stockscreener-App
0.3221
6.44%
0.0195
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BMRA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.3026
Offen:
$0.3026
24-Stunden-Volumen:
8.05M
Relative Volume:
14.51
Marktkapitalisierung:
$5.42M
Einnahmen:
$5.41M
Nettoeinkommen (Verlust:
$-6.35M
KGV:
-0.6442
EPS:
-0.5
Netto-Cashflow:
$-5.39M
1W Leistung:
-0.68%
1M Leistung:
+9.19%
6M Leistung:
-48.55%
1J Leistung:
-64.60%
1-Tages-Spanne:
$0.3026
$0.34
1-Wochen-Bereich:
$0.3022
$0.34
52-Wochen-Spanne:
$0.2415
$2.13
Biomerica Inc Stock (BMRA) Company Profile
Firmenname
Biomerica Inc
Sektor
Branche
Telefon
(949) 379-2875
Adresse
17571 VON KARMAN AVENUE, IRVINE, CA
Vergleichen Sie BMRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
0.3221 | 5.42M | 5.41M | -6.35M | -5.39M | -0.50 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-10 | Eingeleitet | Colliers Securities | Buy |
| 2018-01-04 | Eingeleitet | B. Riley FBR, Inc. | Buy |
Biomerica Inc Aktie (BMRA) Neueste Nachrichten
Biomerica secures patents for GI treatments in Europe By Investing.com - Investing.com South Africa
Biomerica secures patents for GI treatments in Europe - Investing.com India
Biomerica Secures Three Key International Patents for inFoods® Technology to Address GERD, Crohn's Disease, and Ulcerative Colitis - The Manila Times
Biomerica Secures Major European Patents for $8B+ Disease Treatment Technology | BMRA Stock News - StockTitan
Granahan Investment Management Reduces Stake in Biomerica Inc - GuruFocus.com
Biomerica granted Nasdaq compliance extension By Investing.com - Investing.com South Africa
Biomerica granted Nasdaq compliance extension - Investing.com India
Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements - The Manila Times
Biomerica granted extension to regain Nasdaq compliance - Investing.com India
Biomerica granted extension to regain Nasdaq compliance By Investing.com - Investing.com Canada
Biomerica Gains on IBS Announcement - Baystreet.ca
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain - The Manila Times
Biomerica Reports First Quarter Fiscal 2025 Financial Results - The Manila Times
Japan Point of Care Test Market By Application - Third Eye News
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test - Quantisnow
Blood Testing Market Size, Growth, Opportunities 2024-2032 | - openPR
Blood Testing Instrument Market 2031 Research Report, Growth Trends And Competition | Genteel, Baxter, Danaher, Hologic, Biomerica, Meridian Bioscience, Abbott – Times-BD24 - Times-BD24
Blood Testing Market Reaches USD 169.15 Billion by 2032 Due - GlobeNewswire
Artificial intelligence: who are the leaders in personalized food recommendation for the consumer industry? - just-food.com
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Increases By 582.1% - Defense World
Industrial Microbiology Market Share and Size 2024 In The Latest Report - WhaTech
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Bokf Na Acquires Shares of 375 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Cut to $115.00 by Analysts at Bank of America - Defense World
BioMarin price target lowered to $115 from $130 at BofA - TipRanks
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Acadian Asset Management LLC - Defense World
BioE3 Policy implementation and potential in Futuristic growth of J&K - Daily Excelsior
Nasdaq Gains 100 Points; Biomerica Shares Spike Higher - MSN
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Views of Wall Street’s Leading Experts on Biomerica Inc. - SETE News
Biomerica Inc. [BMRA] Stock trading around $0.38 per share: What’s Next? - The DBT News
BMRA’s 2023 Market Dance: Down -70.48% – Time to Invest? - The InvestChronicle
Saudi Arabia approves Biomerica's prostate cancer test - Investing.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica’s At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - ForexTV.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - StockTitan
Financial Metrics Exploration: Understanding Biomerica Inc. (BMRA) Through Ratios - The Dwinnex
Biomerica Full Year 2024 Earnings: US$0.35 loss per share (vs US$0.50 loss in FY 2023) - Yahoo Finance
Biomerica Reports Fiscal 2024 Year End Results - ForexTV.com
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average of $0.66 - Defense World
Biomerica stock plunges to 52-week low of $0.28 - Investing.com India
Biomerica (NASDAQ:BMRA) Share Price Crosses Below 200 Day Moving Average of $0.76 - Defense World
Salmonella Testing Market Anticipated To Reach A CAGR Of 7.8% By 2031, Share, Size, Growth, Demand, And Seg... - WhaTech
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 54.4% in June - Defense World
BMRABiomerica, Inc. Latest Stock News & Market Updates - StockTitan
Biomerica (NASDAQ:BMRA) Stock Passes Below 200-Day Moving Average of $0.83 - Defense World
Is Biomerica Inc. (BMRA) a good investment opportunity? – US Post News - US Post News
Financial Analysis: Biomerica Inc. (BMRA)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers - StockTitan
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS ... - Afternoon Headlines
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average of $0.86 - Defense World
Finanzdaten der Biomerica Inc-Aktie (BMRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):